THE V122I MUTATION IN HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IS SIGNIFICANTLY ASSOCIATED WITH AN INCREASED INCIDENCE OF POLYNEUROPATHY

被引：0
作者：
Parker, Margaret
Damrauer, Scott
Erbe, David
Aldinc, Emre
Ticau, Simina
Flynn-Caroll, Alexander
Deaton, Aimee
Ward, Lucas
Rader, Daniel
Fitzgerald, Kevin
Vaishnaw, Akshay
Hinkle, Gregory
Nioi, Paul
机构：
来源：
MUSCLE & NERVE | 2020年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
198
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
[41]   Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy [J].
Merkel, Madeline ;
Danese, David ;
Chen, Chongshu ;
Wang, Jessie ;
Wu, Aozhou ;
Yang, Hongbo ;
Lin, Hollis .
EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (10) :1205-1214
[42]   Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy [J].
Laura Obici ;
Senda Ajroud-Driss ;
Kon-Ping Lin ;
John L. Berk ;
Julian D. Gillmore ;
Parag Kale ;
Haruki Koike ;
David Danese ;
Emre Aldinc ;
Chongshu Chen ;
John Vest ;
David Adams .
Neurology and Therapy, 2023, 12 (5) :1759-1775
[43]   Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis [J].
Thenappan, Thenappan ;
Fedson, Savitri ;
Rich, Jonathan ;
Murks, Catherine ;
Husain, Aliya ;
Pogoriler, Jennifer ;
Anderson, Allen S. .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2014, 21 (02) :120-123
[44]   Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy [J].
Carr, A. S. ;
Pelayo-Negro, A. L. ;
Jaunmuktane, Z. ;
Scalco, R. S. ;
Hutt, D. ;
Evans, M. R. B. ;
Heally, E. ;
Brandner, S. ;
Holton, J. ;
Blake, J. ;
Whelan, C. J. ;
Wechalekar, A. D. ;
Gillmore, J. D. ;
Hawkins, P. N. ;
Reilly, M. M. .
NEUROMUSCULAR DISORDERS, 2015, 25 (06) :511-515
[45]   Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis [J].
Hamour, I. M. ;
Lachmann, H. J. ;
Goodman, H. J. B. ;
Petrou, M. ;
Burke, M. M. ;
Hawkins, P. N. ;
Banner, N. R. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (05) :1056-1059
[46]   COST OF INOTERSEN AND PATISIRAN FOR THE TREATMENT OF ADULTS WITH POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IN CANADA, GERMANY, AND ITALY [J].
Brown, D. ;
Vera-Llonch, M. ;
Shaff, M. ;
Rolli, A. ;
Vega, M. ;
Blum, M. ;
Nestler-Parr, S. ;
Jiresch, M. ;
Weycker, D. .
VALUE IN HEALTH, 2020, 23 :S606-S607
[47]   LONG-TERM, INTEGRATED CARDIAC SAFETY OF PATISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY [J].
Dispenzieri, Angela ;
Gillmore, Julian ;
Polydefkis, Michael ;
Plante-Bordeneuve, Violaine ;
Schmidt, Hartmut ;
Berber, Erhan ;
Wang, Jing Jing ;
Sweetser, Marianne ;
White, Matthew ;
Maurer, Mathew .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) :690-690
[48]   HELIOS-A: IMPACT OF VUTRISIRAN ON QUALITY OF LIFE AND FUNCTIONAL STATUS IN HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY [J].
Ajroud-Driss, Senda ;
Berk, John ;
Adams, David ;
Gillmore, Julian D. ;
Lin, Kon-Ping ;
Kale, Parag ;
Koike, Haruki ;
Aldinc, Emre ;
Chen, Chongshu ;
Vest, John ;
Obici, Laura .
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 :S6-S6
[49]   Prevalence of peripheral polyneuropathy in patients with cardiomyopathy secondary to hereditary transthyretin amyloidosis and V142I mutation [J].
Brewster, A. ;
Keck, J. M. ;
Baird, M. ;
Bacon, S. ;
Shirwany, A. ;
Yaranov, D. .
EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 :84-85
[50]   Use of Commercial Claims Data to Estimate Hereditary Transthyretin-Mediated Amyloidosis Prevalence and Incidence in the US [J].
Brown, Duncan ;
Vera-Llonch, Montserrat ;
Ortiz, Jose Tomas ;
Reddy, Sheila R. ;
Chang, Eunice ;
Tarbox, Marian H. ;
Nativi-Nicolau, Jose ;
Fine, Nowell M. .
NEUROLOGY, 2021, 96 (15)
12345